Nov 03, 2026 6:30am EST Stevanato Group Delivers 8% Revenue Growth for the Third Quarter of Fiscal 2026
Oct 27, 2026 7:00am EDT Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection
Oct 20, 2026 4:30pm EDT Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026
Aug 04, 2026 6:30am EDT Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026
Jul 30, 2026 6:30am EDT Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries
Jul 21, 2026 6:30am EDT Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026
Jun 08, 2026 6:30am EDT Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management
Jun 03, 2026 5:45pm EDT Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting
May 07, 2026 6:30am EDT Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026